Related Experiment Video
Updated: Dec 29, 2025

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.1K
Extremity Soft Tissue Sarcoma: Role of Local Control.
Elyse J Brinkmann1, Safia K Ahmed2, Matthew T Houdek3
1Department of Orthopedic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Current Treatment Options in Oncology
|February 7, 2020
Summary
Localized extremity soft tissue sarcoma (eSTS) treatment requires a multidisciplinary team. Limb-salvage surgery, often with radiation therapy, is standard, but chemotherapy is not recommended for all eSTS patients.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Localized extremity soft tissue sarcoma (eSTS) is rare and requires specialized care.
- Treatment for eSTS is highly individualized and managed by multidisciplinary teams at sarcoma centers.
- Current treatment paradigms focus on limb-sparing approaches.
Purpose of the Study:
- To provide an opinion statement on the optimal management of localized extremity soft tissue sarcoma.
- To outline the roles of surgery, radiation therapy, and chemotherapy in eSTS treatment.
- To emphasize the importance of specialized care and surgical expertise.
Main Methods:
- This is an opinion statement based on current evidence and expert consensus.
- Recommendations are derived from the analysis of existing literature on eSTS management.
- Clinical experience from specialized sarcoma centers informs the guidelines.
Main Results:
- Limb-salvage surgery is the cornerstone of eSTS treatment, ideally performed by fellowship-trained surgeons.
- Radiation therapy is crucial for achieving negative margins when wide resection is not feasible, preserving critical structures.
- Surgery alone may suffice for select small, low-grade, superficial tumors with wide margins (>2 cm).
Conclusions:
- Preoperative radiation and wide re-excision are recommended for inadvertent excisions due to high residual tumor rates.
- Radiotherapy is well-supported for enhancing local tumor control in eSTS.
- Evidence supporting chemotherapy for local control in eSTS is lacking, thus it is not universally recommended.

